This is how you balance Mad Money stock picks with your own portfolio.   Read More

This biotech sells its treatment to a niche clientele for big money.   Read More

Genzyme may make orphan drugs, but this company is a lot closer to Daddy Warbucks.   Read More

With Roche set to scoop up Genentech, which biotech is probably the next blockbuster?   Read More

The debate about whether stocks are finding a floor is gaining momentum, but traders agree it's the earnings season that will help decide the details.    Read More

The Dow rose Tuesday in another turbulent session after a pullback in oil prices eased worries about consumer and business spending. What's the "Word on the Street?"   Read More

New hope that the credit crisis is nearing an end sends stocks soaring as investors say good riddance to Q1. Also, the latest on Microsoft-Yahoo, Merck and Schering and more.   Read More

Shares of Merck and Schering-Plough are both under the weather Monday after a study said their Vytorin cholesterol drug isn't any better than a generic. Who wins and who loses?   Read More

Following are the day’s biggest winners and losers. Find out why shares of Waste Management and Jones Apparel popped while Genzyme and Dean Foods dropped.   Read More